Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2012

Tatsas AD, Owens CL, Siddiqui MT, Hruban RH, Ali SZ. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol. 2012;120(4):261-8.

Vashistha H, Singhal PC, Malhotra A, Husain M, Mathieson P, Saleem MA, et al. Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol. 2012;303(12):F1629-40.

Lee SH, Baday M, Tjioe M, Simonson PD, Zhang R, Cai E, et al. Using fixed fiduciary markers for stage drift correction. Opt Express. 2012;20(11):12177-83.

Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, Ghosh P, et al. microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discov. 2012;2(8):736-49.

Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E, et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 2012;120(6):1274-81.

Rand JH, Wolgast LR. Dos and don'ts in diagnosing antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2012;2012:455-9.

Arinsburg SA, Shaz BH, Westhoff C, Cushing MM. Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Am J Hematol. 2012;87(5):525-8.

Beninato T, Kleiman DA, Scognamiglio T, Fahey TJ, Zarnegar R. Tract recurrence of a follicular thyroid neoplasm following transaxillary endoscopic thyroidectomy. Thyroid. 2012;22(2):214-7.

Hurley PJ, Marchionni L, Simons BW, Ross AE, Peskoe SB, Miller RM, et al. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proc Natl Acad Sci U S A. 2012;109(37):14977-82.

Boiocchi L, Orazi A, Ghanima W, Arabadjief M, Bussel JB, Geyer JT. Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities. Mod Pathol. 2012;25(1):65-74.